LogoThread Easy
  • Explorer
  • Composer un thread
LogoThread Easy

Votre partenaire tout-en-un pour les threads Twitter

© 2025 Thread Easy All Rights Reserved.

Explorer

Newest first — browse tweet threads

Keep on to blur preview images; turn off to show them clearly

Nano Banana Pro 🍌提示词

很多人去过同一个景点,但你的体验是独一无二的。把地标装进瓶子里。

下方依旧有地点相关的文字介绍,你可以改成你自己的感想

打印出来也很有意义,提示词太长放下面了👇

Nano Banana Pro 🍌提示词 很多人去过同一个景点,但你的体验是独一无二的。把地标装进瓶子里。 下方依旧有地点相关的文字介绍,你可以改成你自己的感想 打印出来也很有意义,提示词太长放下面了👇

提示词: 海报设计、自媒体封面设计:查找 [在此处输入地点名称 或 经纬度坐标] 的标志性景观或建筑,并获取该地点在特定时间的天气状况。 画面的主体是一个极其精致、透亮且带有厚度感的玻璃罐子(类似于圆顶玻璃罩、标本罐或复古水晶球),稳稳地放置在一个干净、柔和的平面上。玻璃罐子内部,封存着该地点代表性景观的Q版微缩模型。模型材质呈现出高级的软润感(类似软陶或磨砂树脂),色彩治愈。在罐内景观的上方,悬浮着对应天气的微缩模型(例如:Q版棉花糖般的云朵、发光的小太阳、或几滴晶莹的雨滴)。 风格为梦工厂动画风格,3D建模,光线极为柔和梦幻。强调玻璃材质的真实感,光线透过玻璃罐产生漂亮的折射、反光和焦散效果,让内部的景物显得更加珍贵。采用强烈的移轴摄影镜头效果,焦点清晰地集中在玻璃罐内的微缩景观上,罐子外部和背景完全虚化模糊。 画面周围大面积留白,保持干净高级感。画面底部居中位置,使用无衬线体小字清晰标注:位置信息(地点名称及具体的经纬度)、天气图标及温度、时间,以及一段关于这个旅行地点的精简中文介绍文案(侧重于描述记忆或氛围)。高品质画面输出,细节丰富惊人。

avatar for 歸藏(guizang.ai)
歸藏(guizang.ai)
Wed Dec 03 02:05:06
RT @indie_maker_fox: 📢  MkSaaS模板已恢复原价

整个11月份是促销月,这个月确实很忙,也很值得

在迭代模板的同时,还上线了MkDollar网站,很有意思

12月继续加油,这个月计划写一个年终总结,敬请期待 https://t.co/hSSrEf…

RT @indie_maker_fox: 📢 MkSaaS模板已恢复原价 整个11月份是促销月,这个月确实很忙,也很值得 在迭代模板的同时,还上线了MkDollar网站,很有意思 12月继续加油,这个月计划写一个年终总结,敬请期待 https://t.co/hSSrEf…

🔥 The best AI SaaS boilerplate - https://t.co/VyNtTs0jSX 🚀 The best directory boilerplate with AI - https://t.co/wEvJ1Dd8aR 🎉 https://t.co/bh1RxeERuY & https://t.co/zubXJCoY92 & https://t.co/tfQf8T7gGF

avatar for Fox@MkSaaS.com
Fox@MkSaaS.com
Wed Dec 03 02:00:36
RT @ArtificialAnlys: Mistral just launched their new large open weights model, Mistral Large 3 (675B total, 41B active), alongside a set of…

RT @ArtificialAnlys: Mistral just launched their new large open weights model, Mistral Large 3 (675B total, 41B active), alongside a set of…

gpu enjoyer at @modal. he/him. ex @full_stack_dl, @weights_biases (acq. @CoreWeave), phd Berkeley @Redwood_Neuro. try https://t.co/SYWVMCazZ3

avatar for Charles 🎉 Frye @ NeurIPS
Charles 🎉 Frye @ NeurIPS
Wed Dec 03 01:59:20
Congratulations to Faster R-CNN on the test of time award at #NeurIPS2025 

We are entering the 5 year period where folks at FAIR CV group (@metaai) are going to be recognized for the foundations they laid down 10 years ago. One of kind era.

Congratulations to Faster R-CNN on the test of time award at #NeurIPS2025 We are entering the 5 year period where folks at FAIR CV group (@metaai) are going to be recognized for the foundations they laid down 10 years ago. One of kind era.

Co-founder & Chief Scientist @yutori_ai. Prev: Senior Director leading FAIR Embodied AI @MetaAI and Professor @GeorgiaTech.

avatar for Dhruv Batra ✈️ NeurIPS
Dhruv Batra ✈️ NeurIPS
Wed Dec 03 01:57:57
公众号排版样式分享:AI写的CSS代码真香

让 AI 帮写了两个公众号排版样式。

字体、间距、加粗调的基本符合自己预期。

你可以在CSS代码基础上,让AI优化改成自己的风格。

需要的留言评论

公众号排版样式分享:AI写的CSS代码真香 让 AI 帮写了两个公众号排版样式。 字体、间距、加粗调的基本符合自己预期。 你可以在CSS代码基础上,让AI优化改成自己的风格。 需要的留言评论

开源地址 https://t.co/0gUzgVQwxv

avatar for 向阳乔木
向阳乔木
Wed Dec 03 01:57:29
This week on  @FreeRadicalsBio, @teleodaniel  and I are joined by the electric @ladanuzhna, Founder and CEO of General Control, a biotech startup developing targeted epigenetic editing tools to treat diseases of aging backed by @age1vc  and @fiftyyears . 

In this conversation, we discuss Lada’s inspiration to start General Control, why biotech has failed to address aging, and how we can change biotech to accelerate longevity.

Lada is a singularly impressive thinker and individual and this is a must listen conversation for anyone interested in why biotech R&D is broken and how we can fix it to treat aging.

0:00:00 Intro 
00:02:12 First principles biology 
00:06:43 We don’t collect enough of the right data for aging 
00:09:41 Impetus grants funds novel rather than incremental science 
00:12:52 Academic funding environment is dramatically changing 
00:16:08 Incentives are misaligned to fund longevity therapies in the US 
00:19:49 Are GLP-1s a longevity drug? 
00:21:49 Lada’s startup: scalpel-like epigenetic editing
00:35:08 Everyone is using aging clocks but we don’t know what they’re doing 
00:42:10 We don’t have good animal models for aging
00:45:54 The two types of longevity companies
00:48:30 Where are all the trillion-dollar biotechs
00:52:07 Will AI help us develop the next blockbusters
00:54:52 Platform biotechs 
00:59:04 Lightning round

This week on @FreeRadicalsBio, @teleodaniel and I are joined by the electric @ladanuzhna, Founder and CEO of General Control, a biotech startup developing targeted epigenetic editing tools to treat diseases of aging backed by @age1vc and @fiftyyears . In this conversation, we discuss Lada’s inspiration to start General Control, why biotech has failed to address aging, and how we can change biotech to accelerate longevity. Lada is a singularly impressive thinker and individual and this is a must listen conversation for anyone interested in why biotech R&D is broken and how we can fix it to treat aging. 0:00:00 Intro 00:02:12 First principles biology 00:06:43 We don’t collect enough of the right data for aging 00:09:41 Impetus grants funds novel rather than incremental science 00:12:52 Academic funding environment is dramatically changing 00:16:08 Incentives are misaligned to fund longevity therapies in the US 00:19:49 Are GLP-1s a longevity drug? 00:21:49 Lada’s startup: scalpel-like epigenetic editing 00:35:08 Everyone is using aging clocks but we don’t know what they’re doing 00:42:10 We don’t have good animal models for aging 00:45:54 The two types of longevity companies 00:48:30 Where are all the trillion-dollar biotechs 00:52:07 Will AI help us develop the next blockbusters 00:54:52 Platform biotechs 00:59:04 Lightning round

bio x tech || per vita ad astra || podcast @freeradicalsbio

avatar for Eric Dai
Eric Dai
Wed Dec 03 01:57:09
  • Previous
  • 1
  • More pages
  • 1747
  • 1748
  • 1749
  • More pages
  • 5634
  • Next